BioCardia Alpha and Beta Analysis

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioCardia. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioCardia over a specified time horizon. Remember, high BioCardia's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioCardia's market risk premium analysis include:
Beta
0.56
Alpha
1.62
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although BioCardia alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, BioCardia did 1.62  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of BioCardia stock's relative risk over its benchmark. BioCardia has a beta of 0.56  . As returns on the market increase, BioCardia's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioCardia is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

BioCardia Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioCardia market risk premium is the additional return an investor will receive from holding BioCardia long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioCardia. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioCardia's performance over market.
α1.62   β0.56

BioCardia Fundamentals Vs Peers

Comparing BioCardia's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioCardia's direct or indirect competition across all of the common fundamentals between BioCardia and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioCardia or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioCardia's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioCardia by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare BioCardia to competition
FundamentalsBioCardiaPeer Average
Return On Equity-7.04-0.31
Return On Asset-1.33-0.14
Operating Margin(41.36) %(5.51) %
Number Of Shares Shorted4.26 K4.71 M
Revenue477 K9.43 B
EBITDA(11.23 M)3.9 B
Net Income(11.57 M)570.98 M

BioCardia Opportunities

BioCardia Return and Market Media

The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family - StockTitan
07/30/2024

About BioCardia Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioCardia or other delisted stocks. Alpha measures the amount that position in BioCardia has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioCardia in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioCardia's short interest history, or implied volatility extrapolated from BioCardia options trading.

Build Portfolio with BioCardia

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in BioCardia Stock

If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.